NEW YORK (TheStreet) -- Nestle (NSRGY) CEO Paul Bulcke defended the company's large structure, saying it allows Nestle to scale up functions such as R&D that aid the entire group. Size works well, he said, as long as the front end of the businesses can operate independently, he told Reuters.
While Nestle is reducing its huge range of businesses and moving deeper into niche medical products to improve returns, the food and beverage giant still likes its heft.
Last year Nestle missed its long-term forecast for sales growth of 5% to 6%, and many analysts think that even with investments in faster-growing areas like medical nutrition and dermatology, Nestle is just too big to move the needle, Reuters reports.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts